Kura Oncology (KURA) Prepaid Assets (2010 - 2026)
Kura Oncology's (KURA) quarterly Prepaid Assets came in at $32.8 million in Q1 2026, up 89.84% year-on-year from $17.3 million in Q1 2025, and up 1.75% on a QoQ basis from $32.2 million in Q4 2025.
Kura Oncology (KURA) Prepaid Assets (2010 - 2026) Analysis & Trends
Kura Oncology (KURA) has 17 years of Prepaid Assets data on file, last reported at $32.8 million in Q1 2026.
- On a quarterly basis, Prepaid Assets rose 89.84% year-over-year to $32.8 million in Q1 2026; TTM through Mar 2026 was $32.8 million, a 89.84% increase from a year earlier, with the FY2025 full-year figure at $32.2 million, up 109.48% from the prior year.
- Prepaid Assets for Q1 2026 stood at $32.8 million, up from $32.2 million in the prior quarter.
- Over the last five years, Prepaid Assets for KURA reached as high as $35.1 million in Q3 2025 and fell as low as $7.0 million in Q1 2022.
- Historically, Prepaid Assets has averaged $14.9 million across 5 years, with a median of $9.5 million in 2022.
- Across the five-year window, Prepaid Assets fell 15.0% in 2023 and jumped 344.27% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $8.4 million in 2022, then gained by 0.98% to $8.5 million in 2023, then jumped by 80.36% to $15.4 million in 2024, then jumped by 109.48% to $32.2 million in 2025, then climbed by 1.75% to $32.8 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $32.8 million in Q1 2026, $32.2 million in Q4 2025, and $35.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Kura Oncology | 925.97 Mn | 925.97 Mn | 18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.77 Mn |
| Dec 31, 2025 | 32.21 Mn |
| Sep 30, 2025 | 35.06 Mn |
| Jun 30, 2025 | 24.77 Mn |
| Mar 31, 2025 | 17.26 Mn |
| Dec 31, 2024 | 15.37 Mn |
| Sep 30, 2024 | 7.89 Mn |
| Jun 30, 2024 | 8.25 Mn |
| Mar 31, 2024 | 10.71 Mn |
| Dec 31, 2023 | 8.52 Mn |
| Sep 30, 2023 | 7.32 Mn |
| Jun 30, 2023 | 8.67 Mn |
| Mar 31, 2023 | 10.55 Mn |
| Dec 31, 2022 | 8.44 Mn |
| Sep 30, 2022 | 8.62 Mn |
| Jun 30, 2022 | 9.53 Mn |
| Mar 31, 2022 | 6.96 Mn |
| Dec 31, 2021 | 4.33 Mn |
| Sep 30, 2021 | 5.46 Mn |
| Jun 30, 2021 | 6.14 Mn |